ORIGINAL ARTICLESirolimus vs mycophenolate mofetil (MMF) in primary combined pancreas and kidney transplantation. Results of a long-term prospective randomized study
Under a Creative Commons license
open archive
KEYWORDS
clinical research/practice
diabetes: type 1
immunosuppressant - mechanistic target of rapamycin: sirolimus
pancreas/simultaneous pancreas-kidney transplantation
Abbreviations
CNI
calcineurin inhibitor
MMF
mycophenolate mofetil
mTOR
mammalian target of rapamycin
PDRI
Pancreas Donor Risk Index
PRA
panel reactive antibodies
Siro
sirolimus
Cited by (0)
Copyright © 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.